GHK-Cu — the tripeptide Glycine-L-Histidine-L-Lysine in complex with copper(II) — is one of the most extensively studied naturally occurring peptide-metal complexes in the scientific literature. First identified in 1973 by Loren Pickart from human plasma albumin fractions, GHK was characterized as a copper-binding tripeptide present endogenously in human plasma, saliva, and urine. Since its isolation, GHK-Cu has been the subject of over 50 years of peer-reviewed investigation, with research spanning gene regulation, antioxidant biology, wound healing models, and cellular signaling.

This article provides a comprehensive research overview of GHK-Cu for laboratory scientists — covering its biochemical properties, proposed mechanisms of action documented in the peer-reviewed literature, relevant in-vitro research models, and handling considerations for research use.

Research Use Reminder: GHK-Cu is sold exclusively for in-vitro and preclinical laboratory research. It is not approved by the FDA for any therapeutic application. All research summaries below reflect findings from published preclinical studies and are presented solely for scientific context.

Biochemical Identity & Structural Properties

GHK is a tripeptide composed of glycine, L-histidine, and L-lysine. In its copper complex form (GHK-Cu), the molecule coordinates a Cu²⁺ ion through the nitrogen atoms of the glycine amine, the histidine imidazole, and the deprotonated amide nitrogen between glycine and histidine. This square-planar coordination geometry provides the complex with remarkable stability and biological activity distinct from either the free peptide or free copper ion alone.

PropertyValue
Full NameCopper(II) complex of Glycine-L-Histidine-L-Lysine
AbbreviationGHK-Cu
Molecular Formula (GHK free base)C₁₄H₂₃N₆O₄⁺
Molecular Weight (GHK)~340.4 Da
CAS Number49557-75-7 (GHK·Cu complex)
SolubilityHighly water-soluble
Storage (lyophilized)−20°C, desiccated, light-protected
ReconstitutionSterile water or PBS; stable 2–8°C for up to 14 days
First Isolated1973, Pickart L, Thaler MM (J Biol Chem)

Gene Regulation & Proposed Mechanisms of Action

Among the most striking characteristics documented in the GHK-Cu literature is its apparent capacity to modulate gene expression across a wide range of biological pathways. A landmark gene array study by Pickart and Margolina (2018) analyzed published microarray data and identified GHK-Cu as capable of up- or down-regulating over 4,000 human genes — including numerous genes associated with inflammation, oxidative stress, DNA repair, and tissue remodeling.

Collagen Synthesis Pathways

Research in fibroblast cell models has consistently documented GHK-Cu's influence on collagen-related gene expression. Studies have reported upregulation of COL1A1 and COL3A1 transcripts following GHK-Cu exposure in human dermal fibroblast cultures. Research by Siméon et al. (2000) demonstrated GHK-Cu's apparent role in activating transforming growth factor-β1 (TGF-β1) secretion in fibroblast models — a key upstream regulator of collagen synthesis gene expression. Investigators using collagen gel contraction assays have explored how GHK-Cu concentration gradients influence fibroblast-mediated matrix remodeling.

Antioxidant Defense Systems

GHK-Cu has been studied for its interaction with cellular antioxidant defense pathways. Research has documented apparent induction of superoxide dismutase (SOD) and catalase activity in oxidative stress cell models. Additionally, studies have reported GHK-Cu upregulation of metallothionein — a cysteine-rich protein involved in metal ion homeostasis and reactive oxygen species scavenging. These findings have positioned GHK-Cu as a compound of interest in oxidative biology research platforms investigating cellular responses to exogenous antioxidant peptide compounds.

Anti-Inflammatory Gene Networks

In inflammatory cell models, GHK-Cu has been associated with suppression of NF-κB transcriptional activity. Research has documented apparent reductions in pro-inflammatory cytokine gene expression — including TNF-α and IL-6 — in GHK-Cu-treated macrophage cell models. These findings parallel the compound's observed effects on pain signaling gene networks documented in animal model research, providing in-vitro investigative leads for researchers studying inflammatory pathway modulation.

Angiogenic Signaling

Tube formation assays using human umbilical vein endothelial cells (HUVECs) have been used to examine GHK-Cu's apparent effects on angiogenic behavior. Research has documented upregulation of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression in GHK-Cu-treated endothelial cell cultures, making it a compound of interest for vascular biology research platforms.

DNA Repair & Chromatin Remodeling

An emerging area of GHK-Cu research concerns its apparent influence on DNA repair gene networks. Bioinformatic analyses of GHK-Cu-responsive gene sets have identified enrichment in pathways related to DNA damage sensing (ATM, BRCA1/2) and nucleotide excision repair. Researchers studying epigenetic regulation have also examined GHK-Cu's apparent effects on histone deacetylase (HDAC) activity in cell culture models, representing an active frontier of in-vitro investigation.

Summary of Published Research Findings

The following represents a representative summary of peer-reviewed findings on GHK-Cu across major research domains:

Important Context: The research findings summarized above derive from in-vitro and preclinical animal models. They represent investigational leads, not clinical evidence. Findings in cell or animal models do not necessarily translate to human biology or therapeutic applications.

Key Published References

Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987. PMID: 29789494

Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. (2000). Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-l-histidyl-l-lysine-Cu²⁺. Journal of Investigative Dermatology, 115(6), 962–968. PMID: 11121130

Pickart L, Thaler MM. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology, 243(124), 85–87. PMID: 4513763

Huang PJ, Huang YC, Su MF, Yang TY, Huang JR, Jiang CP. (2007). In vitro observations on the influence of copper peptide aids for the LED photoirradiation of fibroblast collagen synthesis. Photomedicine and Laser Surgery, 25(3), 183–190. PMID: 17603874

Storage & Laboratory Handling

Why Source Verification Matters for GHK-Cu Research

Copper peptide research presents specific purity challenges. Incorrectly synthesized GHK-Cu may contain free copper ions not bound within the peptide coordination complex — which would produce dramatically different biological effects in cell-based assays (free Cu²⁺ is cytotoxic at concentrations that the GHK-Cu complex tolerates). HPLC purity verification confirms the relative amount of the primary compound, while mass spectrometry confirms the intact molecular weight of the GHK-Cu complex. Both are required for research-grade material.